Increased Level of Serum Wingless-Type Mouse Mammary Tumor Virus Integration Site Family Member 5a in Patients with Cutaneous Lichen Planus

References

• Tziotzios C, Lee JYW, Brier T, et al. Lichen planus and lichenoid dermatoses: clinical overview and molecular basis. J Am Acad Dermatol. 2018;79(5):789–804. doi:10.1016/j.jaad.2018.02.010
   PubMed Web of Science ®Google Scholar
• Le Cleach L, Chosidow O. Clinical practice. Lichen planus. N Engl J Med. 2012;366(8):723–732. doi:10.1056/NEJMcp1103641
   PubMed Web of Science ®Google Scholar
• Weedon D. The lichenoid reaction pattern (interface dermatitis). In: Weedon’s Skin Pathology. 3rd ed. Edinburgh: Elsevier Limited; 2010:35.
   Google Scholar
• Boch K, Langan EA, Kridin K, et al. Lichen Planus. Front Med. 2021;8:737813. doi:10.3389/fmed.2021.737813
   Web of Science ®Google Scholar
• Sugerman PB, Satterwhite K, Bigby M. Autocytotoxic T-cell clones in lichen planus. Br J Dermatol. 2000;142(3):449–456. doi:10.1046/j.1365-2133.2000.03355.x
   PubMed Web of Science ®Google Scholar
• Kastelan M, Prpić Massari L, Gruber F, et al. The role of perforin-mediated apoptosis in lichen planus lesions. Arch Dermatol Res. 2004;296(5):226–230. doi:10.1007/s00403-004-0512-1
   PubMed Web of Science ®Google Scholar
• Kitkhajornkiat A, Rungsiyanont S, Talungchit S, et al. The expression of Cathepsin L in oral lichen planus. J Oral Biol Craniofac Res. 2020;10(3):281–286. doi:10.1016/j.jobcr.2020.06.003
   PubMedGoogle Scholar
• Nusse R, Clevers H. Wnt/beta-catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169(6):985–999. doi:10.1016/j.cell.2017.05.016
   PubMed Web of Science ®Google Scholar
• Kumawat K, Gosens R. WNT-5A: signaling and functions in health and disease. Cell Mol Life Sci. 2016;73(3):567–587. doi:10.1007/s00018-015-2076-y
   PubMed Web of Science ®Google Scholar
• Relling I, Akcay G, Fangmann D, et al. Role of wnt5a in metabolic inflammation in humans. J Clin Endocrinol Metab. 2018;103(11):4253–4264. doi:10.1210/jc.2018-01007
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang D, Tu C, et al. Wnt5a is involved in the pathogenesis of cutaneous lichen planus. Clin Exp Dermatol. 2015;40(6):659–664. doi:10.1111/ced.12561
   PubMed Web of Science ®Google Scholar
• Kumaran MS, Bishnoi A, Srivastava N, et al. Significant reduction in the expression of interleukins-17A, 22 and 23A, forkhead box p3 and interferon gamma delineates lichen planus pigmentosus from lichen planus. Arch Dermatol Res. 2019;311(7):519–527. doi:10.1007/s00403-019-01926-9
   PubMed Web of Science ®Google Scholar
• Lai YC, Yew YW, Schwartz RA. Lichen planus and dyslipidemia: a systematic review and meta-analysis of observational studies. Int J Dermatol. 2016;55(5):295–304. doi:10.1111/ijd.13234
   Web of Science ®Google Scholar
• Daye M, Temiz SA, Isık B. The relationship between lichen planus and metabolic syndrome. J Cosmet Dermatol. 2021;20(8):2635–2639. doi:10.1111/jocd.13905
   PubMed Web of Science ®Google Scholar
• Lehman JS, Tollefson MM, Gibson LE. Lichen planus. Int J Dermatol. 2009;48(7):682–694. doi:10.1111/j.1365-4632.2009.04062.x
   PubMed Web of Science ®Google Scholar
• Sezer E, Ozugurlu F, Ozyurt H, et al. Lipid peroxidation and antioxidant status in lichen planus. Clin Exp Dermatol. 2007;32(4):430–434. doi:10.1111/j.1365-2230.2007.02436.x
   PubMed Web of Science ®Google Scholar
• Atas H, Cemil BC, Kurmus GI, et al. Assessment of systemic inflammation with neutrophil-lymphocyte ratio in lichen planus. Postepy Dermatol Alergol. 2016;33(3):188–192. doi:10.5114/pdia.2016.56930
   PubMed Web of Science ®Google Scholar
• Arias-Santiago S, Buendia-Eisman A, Aneiros-Fernandez J, et al. Lipid levels in patients with lichen planus: a case-control study. J Eur Acad Dermatol Venereol. 2011;25(12):1398–1401. doi:10.1111/j.1468-3083.2011.03983.x
   PubMed Web of Science ®Google Scholar
• Ozbagcivan O, Akarsu S, Semiz F, et al. Comparison of serum lipid parameters between patients with classic cutaneous lichen planus and oral lichen planus. Clin Oral Investig. 2020;24(2):719–725. doi:10.1007/s00784-019-02961-6
   PubMed Web of Science ®Google Scholar
• Wang W, Yu X, Wu C, et al. Differential effects of Wnt5a on the proliferation, differentiation and inflammatory response of keratinocytes. Mol Med Rep. 2018;17(3):4043–4048. doi:10.3892/mmr.2017.8358
   PubMed Web of Science ®Google Scholar
• Żychowska M, Batycka-Baran A, Baran W. Increased serum level and high tissue immunoexpression of interleukin 17 in cutaneous Lichen planus: a novel therapeutic target for recalcitrant cases? Dis Markers. 2020;2020:6521274. doi:10.1155/2020/6521274
   PubMed Web of Science ®Google Scholar
• Weber B, Schlapbach C, Stuck M, et al. Distinct interferon-gamma and interleukin-9 expression in cutaneous and oral lichen planus. J Eur Acad Dermatol Venereol. 2017;31(5):880–886. doi:10.1111/jdv.13989
   PubMed Web of Science ®Google Scholar
• Pashirzad M, Shafiee M, Rahmani F, et al. Role of Wnt5a in the pathogenesis of inflammatory diseases. J Cell Physiol. 2017;232(7):1611–1616. doi:10.1002/jcp.25687
   PubMed Web of Science ®Google Scholar
• Santoro A, Majorana A, Bardellini E, et al. NF-kappaB expression in oral and cutaneous lichen planus. J Pathol. 2003;201(3):466–472. doi:10.1002/path.1423
   PubMed Web of Science ®Google Scholar
• Gerdes S, Laudes M, Neumann K, et al. Wnt5a: a potential factor linking psoriasis to metabolic complications. Exp Dermatol. 2014;23(6):438–440. doi:10.1111/exd.12413
   PubMed Web of Science ®Google Scholar
• Aghamajidi A, Raoufi E, Parsamanesh G, et al. The attentive focus on T cell-mediated autoimmune pathogenesis of psoriasis, lichen planus and vitiligo. Scand J Immunol. 2021;93(4):e13000. doi:10.1111/sji.13000
   PubMed Web of Science ®Google Scholar
• Al-Bachir M, Bakir MA. Predictive value of body mass index to metabolic syndrome risk factors in Syrian adolescents. J Med Case Rep. 2017;11(1):170. doi:10.1186/s13256-017-1315-2
   PubMedGoogle Scholar
• Iyer A, Fairlie DP, Prins JB, et al. Inflammatory lipid mediators in adipocyte function and obesity. Nat Rev Endocrinol. 2010;6(2):71–82. doi:10.1038/nrendo.2009.264
   PubMed Web of Science ®Google Scholar
• Koutaki D, Michos A, Bacopoulou F, et al. The emerging role of Sfrp5 and Wnt5a in the pathogenesis of obesity: implications for a healthy diet and lifestyle. Nutrients. 2021;13(7):2459. doi:10.3390/nu13072459
   PubMed Web of Science ®Google Scholar
• Ouchi N, Higuchi A, Ohashi K, et al. Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science. 2010;329(5990):454–457. doi:10.1126/science.1188280
   PubMed Web of Science ®Google Scholar